Viewing Study NCT02947061


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-14 @ 9:00 PM
Study NCT ID: NCT02947061
Status: UNKNOWN
Last Update Posted: 2016-10-31
First Post: 2016-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast Cancer
Sponsor: Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module